Drug intelligence / Profile preview

MAR003

Development stage: Unknown
Lead developer: Marea Therapeutics

Overview

MAR003 is a biological product in early-stage development by Marea Therapeutics. It is being investigated for the treatment of cardiovascular diseases, specifically atherosclerosis. The drug is currently at the discovery stage, and detailed information about its mechanism of action or molecular target has not been disclosed publicly. Marea Therapeutics focuses on developing novel therapies for cardiometabolic diseases using human genetic data and adipocyte biology, but no specific mechanistic details are available for MAR003 at this time[1][3][9].

Beyond the preview

Go deeper on MAR003.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MAR003.

Explore the full profile